Status:
UNKNOWN
Study of Inflammatory Markers (VNN1) in Crohn Disease and Ulcerative Colitis.
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Inflammatory Bowel diseases (IBD) include Crohn's disease and ulcerative colitis. IBD's precise origin is unknown until now. Today, the current hypothesis of the disease pathogenesis is that IBD resul...
Eligibility Criteria
Inclusion
- Experimental group - Patients with Inflamatroy Bowel Disease
- Control group:
- Patients that are planned to have a colonoscopy from familial history of colon cancer orpolyps or for irritable bowel syndroms
- Both groups:
- free informed consent signed
Exclusion
- Patients with contradication for anesthesia
- Patient undergoind aspirin or anitinflamatory drugs within 72 hours of the colonoscopy
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02304666
Start Date
November 1 2014
End Date
October 1 2018
Last Update
August 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France, 13005